Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia 2Hematologic Neoplasms 2Stomach Neoplasms 1Recurrence 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Nose Neoplasms 1Neoplasm, Residual 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Hairy Cell 1Genital Neoplasms, Female 1Esthesioneuroblastoma, Olfactory 1EGFR-Mutated Non-Small-Cell Lung Carcinoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Appendiceal Neoplasms 1Adenocarcinoma 1

Interventions

Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nose Neoplasms × Electrocardiography × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡